NCT02261636已完成不适用
Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 150
- 试验地点
- 1
- 主要终点
- Time to dose reduction
研究概览
简要总结
For both induction of remission and in maintenance of remission, different doses and treatment durations are used in practice. The aim of this study is to assess how mesalazine is used in clinical practice, at which doses and for how long and how these differences impact the patient disease state and work productivity.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with mild to moderate active ulcerative colitis with disease extension beyond the rectum (≥ 10 cm) who will receive oral Pentasa treatment (Compact sachets and/or tablets) for the treatment of the current active episode or in whom on oral Pentasa maintenance treatment induction of remission treatment will be initiated by dose escalation. Treatment combined with Pentasa enema (1g/100ml) is allowed.
- •Informed consent
排除标准
- •Patients receiving treatment with one or more of the following: locally acting steroids (e.g. budesonide, beclomethasone), systemic steroids, immunosuppressants (e.g. thiopurines), biologicals (e.g. anti-Tumor Necrosis Factor-alpha)
研究组 & 干预措施
Pentasa
Treatment according to standard clinical practice.
干预措施: mesalazine (Drug)
结局指标
主要结局
Time to dose reduction
时间窗: From Day 1 up to one year
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
2 期
Induction of remission and consolidation therapy using ATRA and ATO for acute promyelocytic leukemia - JSCT APL2021Acute promyelocytic leukemiaJPRN-jRCTs071210035Takase Ken90
招募中
不适用
Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative ColitisNCT06095596Sixth Affiliated Hospital, Sun Yat-sen University334
已完成
4 期
Orencia remission Induction and Outcome Navigation Studyrheumatoid arthritisJPRN-UMIN000004137Keio University70
招募中
不适用
Multi-Modal study for the Maintenance of Remission after Electroconvulsive therapy (ECT)DepressionJPRN-UMIN000027827Department of Neuropsychiatry, Keio University School of Medicine100
招募中
不适用
Effectiveness and safety of the combination of drugs tacrolimus and azathioprine in maintenance therapy for SLE nephropathy in comparison with azathioprine alone.CTRI/2019/03/018157IPGMER and SSKM Hospital